Microcin C: biosynthesis and mechanisms of bacterial resistance

Area of Science:

• Microbiology
• Molecular Biology
• Drug Discovery

Background:

• Nonhydrolyzable aminoacyl-adenylates are promising antibiotic candidates due to their protein synthesis inhibition mechanism, which limits bacterial resistance.
• Microcin C (McC) utilizes a peptide carrier as a 'Trojan horse' to deliver a potent aspartyl tRNA synthetase inhibitor into bacterial cells.
• Understanding McC's biosynthesis and the strategies bacteria use to prevent premature drug processing is crucial for antibiotic development.

Purpose of the Study:

• To elucidate the mechanism of microcin C (McC) biosynthesis.
• To examine the protective strategies employed by McC-producing bacteria against self-toxicity.
• To explore the manipulation of McC biosynthesis for developing novel antibiotics targeting aminoacyl tRNA synthetases.

Main Methods:

• Analysis of the microcin C (McC) biosynthetic pathway.
• Investigation of cellular mechanisms preventing premature processing of the antibiotic.
• Bioinformatic and genetic approaches to understand McC production and resistance.

Main Results:

• Detailed insights into the multi-step biosynthesis of the nonhydrolyzable aspartyl-adenylate core of McC.
• Identification of specific bacterial systems that safeguard McC from early degradation.
• Demonstration of McC's potent inhibition of aspartyl tRNA synthetase.

Conclusions:

• The unique 'Trojan horse' strategy of McC provides a novel antibiotic class with a mechanism that circumvents common resistance pathways.
• Understanding McC biosynthesis and processing is key to engineering new derivatives targeting a broad spectrum of bacterial aminoacyl tRNA synthetases.
• Targeted manipulation of McC biosynthesis holds potential for developing next-generation antibiotics against drug-resistant pathogens.